CENTESSA PHARMACEUTICALS CVR from 152309100
13F holders, Q2 2026 (June 30)1holders
$0.00avg. 13F price*
At the end of Q2 2026, 1 institutions reported holding CENTESSA PHARMACEUTICALS CVR from 152309100 in their 13F filings. The largest holder was GAMMA Investing LLC ($0).
- Company
- CENTESSA PHARMACEUTICALS CVR from 152309100
- CUSIP
- 152CVR015
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $0 |
| Exits | 0 | $0 |
Ownership 1 holders
| GAMMA Investing LLC | 0.00% | New | 4,098 | $0 |
"% of holder's portfolio" is CENTESSA PHARMACEUTICALS CVR from 152309100's weight in each manager's 13F, not the share of CENTESSA PHARMACEUTICALS CVR from 152309100 the manager owns.